Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international family stem cell bank, announces that the Board plans to propose a dividend of ?0.08 per share for the year ended 31 December 2011 (2010: ?0.07) , a 14% increase on last year.
For the fourth consecutive year Cryo-Save proposes a dividend increase, indicating the expected growth based on the strong impact of its new products.
Cryo-Save will allow its shareholders to choose between a distribution in shares or in cash.
Further details will be provided when the Group publishes its results for the year ended 31 December 2011 during the week commencing 19 March 2012.
Enquiries:
Cryo-Save Group 31 (0) 575 548 998
Arnoud van Tulder, Chief Executive Officer
SPJ Financiële Communicatie (The Netherlands) 31 (0)20 647 8181
Kees Jongsma/Leon Melens
Daniel Stewart & Company plc (UK) 44 (0) 20 7776 6550
Sean Lunn
College Hill (UK) 44 (0) 20 7457 2020
Rozi Morris/ Adrian Duffield
Free footage is available on www.videobankonline.com.
About Cryo-Save (www.cryo-save.com/group)
Cryo-Save, the leading international family stem cell bank, already stores more than 204,000 samples from cord blood and umbilical cord tissue for newborns and adipose tissue for adults. These stem cells can mean the difference between life and death in the case of future threats to the health of the donors. There are already several diseases that can be treated by the use of stem cells, and the number of treatments will only increase. The use of stem cells from adipose tissue is increasingly popular in plastic surgery. Driven by its international business strategy, Cryo-Save is now represented in over 40 countries on four continents, with ultra-modern processing and storage facilities in the United States, Belgium, Germany, Dubai, India, South Africa and France (validation in progress).
Click here for press release in PDF: http://hugin.info/143308/R/1582821/494656.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Cryo-Save Group N.V. via Thomson Reuters ONE
[HUG#1582821]

Forum
Facebook
Twitter





















